Minerva Neurosciences, Inc. Accounts Payable and Other Accrued Liabilities, Current
Minerva Neurosciences, Inc. (NERV) had Accounts Payable and Other Accrued Liabilities, Current of $2.51 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $2.51M.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $2.36M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $1.65M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $1.73M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.51M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.36M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $1.65M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.63M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.31M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.23M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $3.93M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $3.38M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.40M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $1.54M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $1.95M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.61M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $1.54M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $407.91K 10-K · filed 2024-02-22 | |
| 2022-09-30 | $1.66M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.89M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.66M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $965.74K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $1.88M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $2.83M 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $2.16M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.05M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $4.54M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $4.08M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $3.94M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $4.14M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $4.40M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $4.49M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $3.72M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $1.81M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $3.00M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $2.31M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.81M 10-Q · filed 2019-05-06 | $2.39M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $1.44M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $2.02M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $1.44M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.67M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $815.81K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $980.86K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.48M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $3.10M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $2.52M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $2.22M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.08M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $1.65M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |